Literature DB >> 28475016

Dissecting the roles of the androgen receptor in prostate cancer from molecular perspectives.

Jieping Hu1, Gongxian Wang1, Ting Sun1.   

Abstract

Androgen receptor plays a pivotal role in prostate cancer progression, and androgen deprivation therapy to intercept androgen receptor signal pathway is an indispensable treatment for most advanced prostate cancer patients to delay cancer progression. However, the emerging of castration-resistant prostate cancer reminds us the alteration of androgen receptor, which includes androgen receptor mutation, the formation of androgen receptor variants, and androgen receptor distribution in cancer cells. In this review, we introduce the process of androgen receptor and also its variants' formation, translocation, and function alteration by protein modification or interaction with other pathways. We dissect the roles of androgen receptor in prostate cancer from molecular perspective to provide clues for battling prostate cancer, especially castration-resistant prostate cancer.

Entities:  

Keywords:  Androgen receptor; cell signals; dimerization; translocation; variants

Mesh:

Substances:

Year:  2017        PMID: 28475016     DOI: 10.1177/1010428317692259

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  10 in total

1.  Nuclear loss and cytoplasmic expression of androgen receptor in penile carcinomas: role as a driver event and as a prognosis factor.

Authors:  Hellen Kuasne; Mateus C Barros-Filho; Fábio A Marchi; Sandra A Drigo; Cristovam Scapulatempo-Neto; Eliney F Faria; Silvia R Rogatto
Journal:  Virchows Arch       Date:  2018-08-11       Impact factor: 4.064

2.  Androgen receptor reverts dexamethasone‑induced inhibition of prostate cancer cell proliferation and migration.

Authors:  Ju Guo; Ke Ma; Hai-Mei Xia; Qing-Ke Chen; Lei Li; Jun Deng; Jing Sheng; Yan-Yan Hong; Jie-Ping Hu
Journal:  Mol Med Rep       Date:  2018-02-06       Impact factor: 2.952

Review 3.  Androgen-targeted therapy in men with prostate cancer: evolving practice and future considerations.

Authors:  E David Crawford; Axel Heidenreich; Nathan Lawrentschuk; Bertrand Tombal; Antonio C L Pompeo; Arturo Mendoza-Valdes; Kurt Miller; Frans M J Debruyne; Laurence Klotz
Journal:  Prostate Cancer Prostatic Dis       Date:  2018-08-21       Impact factor: 5.554

Review 4.  ZBTB46, SPDEF, and ETV6: Novel Potential Biomarkers and Therapeutic Targets in Castration-Resistant Prostate Cancer.

Authors:  AbdulFattah Salah Fararjeh; Yen-Nien Liu
Journal:  Int J Mol Sci       Date:  2019-06-08       Impact factor: 5.923

5.  Efficacy and Mechanism of Action of Marine Alkaloid 3,10-Dibromofascaplysin in Drug-Resistant Prostate Cancer Cells.

Authors:  Sergey A Dyshlovoy; Moritz Kaune; Jessica Hauschild; Malte Kriegs; Konstantin Hoffer; Tobias Busenbender; Polina A Smirnova; Maxim E Zhidkov; Ekaterina V Poverennaya; Su Jung Oh-Hohenhorst; Pavel V Spirin; Vladimir S Prassolov; Derya Tilki; Carsten Bokemeyer; Markus Graefen; Gunhild von Amsberg
Journal:  Mar Drugs       Date:  2020-12-01       Impact factor: 5.118

6.  What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 4: Experimental Treatments in Pre-Clinical Studies (Cell Lines and Mouse Models).

Authors:  Andrea Palicelli; Stefania Croci; Alessandra Bisagni; Eleonora Zanetti; Dario De Biase; Beatrice Melli; Francesca Sanguedolce; Moira Ragazzi; Magda Zanelli; Alcides Chaux; Sofia Cañete-Portillo; Maria Paola Bonasoni; Alessandra Soriano; Stefano Ascani; Maurizio Zizzo; Carolina Castro Ruiz; Antonio De Leo; Guido Giordano; Matteo Landriscina; Giuseppe Carrieri; Luigi Cormio; Daniel M Berney; Jatin Gandhi; Giacomo Santandrea; Martina Bonacini
Journal:  Int J Mol Sci       Date:  2021-11-14       Impact factor: 5.923

7.  The T850D Phosphomimetic Mutation in the Androgen Receptor Ligand Binding Domain Enhances Recruitment at Activation Function 2.

Authors:  Christine Helsen; Tien Nguyen; Thomas Vercruysse; Staf Wouters; Dirk Daelemans; Arnout Voet; Frank Claessens
Journal:  Int J Mol Sci       Date:  2022-01-29       Impact factor: 5.923

Review 8.  Evolution of Androgen Deprivation Therapy (ADT) and Its New Emerging Modalities in Prostate Cancer: An Update for Practicing Urologists, Clinicians and Medical Providers.

Authors:  Erin Choi; John Buie; Jaime Camacho; Pranav Sharma; Werner T W de Riese
Journal:  Res Rep Urol       Date:  2022-03-30

9.  Marine alkaloid monanchoxymycalin C: a new specific activator of JNK1/2 kinase with anticancer properties.

Authors:  Sergey A Dyshlovoy; Moritz Kaune; Malte Kriegs; Jessica Hauschild; Tobias Busenbender; Larisa K Shubina; Tatyana N Makarieva; Konstantin Hoffer; Carsten Bokemeyer; Markus Graefen; Valentin A Stonik; Gunhild von Amsberg
Journal:  Sci Rep       Date:  2020-08-06       Impact factor: 4.379

10.  Clinicopathological and prognostic significance of androgen receptor overexpression in colorectal cancer. Experience from Al-Madinah Al-Munawarah, Saudi Arabia.

Authors:  Abdulkader M Albasri; Mohammed A Elkablawy
Journal:  Saudi Med J       Date:  2019-09       Impact factor: 1.484

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.